On Tuesday, researchers announced that a three-drug cocktail may help women with HER2-positive breast cancer better than any other drug used on its own. About one quarter of women with breast cancer make up this HER2 category.

Tests on mice revealed using the three drugs along with breast cancer drug tamoxifen helped wipe out tumors altogether. And the tumors did not come back. This is the first time mice were cured of a very aggressive human breast tumor. Incidentally, when a single drug was used, tumors returned within several weeks.

The three wonder drugs used in this study -- all are monoclonal antibodies that precisely target certain aspects of tumors -- are the experimental drug pertuzumab; trastuzumab, also known as Herceptin; and gefitinib, or Iressa.

Published in the Journal of the National Cancer Institute, this study supports the notion that HER2-positive tumors eventually become resistant to one drug and attacking them on several fronts seems to work better.

The most healthy thing that I have added to my daily menu to fight cancer right now is this simple drink that helps give me energy and gives me antioxidants and vitamins. It helps boost the immune system. It detoxifies and cleanses the body. It gives a quota of daily veggies. It has a high alkalinity that helps balance acid PH levels in the body. It is simple and it tastes good too.

Vicki's Twice Daily Wheat Grass Cocktail
4 ounces of organic tangerine juice
4 ounces of organic carrot juice
1 organic banana
1 8 grams packet of Organic Wheat Grass (I prefer Amazing Grass brand)

Mix together well in a blender until smooth and pour into a large glass.

You can find Wheat Grass in your local health food store.

Among all sorts of news circulating as a result of the recent breast cancer conference in San Antonio, Texas is a report about an international study that has many touting Canadian chemotherapy treatments as the best therapies around -- even better than the commonly-used AC/T cocktail (doxorubicin and cyclophosphamide followed by paclitaxel) .

The winning Canadian drug combinations -- EC/T (epirubicin and cyclophosphamide followed by paclitaxel) and CEF (cyclophosphamide, epirubicin, and fluorouracil) -- are reportedly more effective at preventing breast cancer recurrence than AC/T.

About 2,104 women in Canada and the United States participated in this international study. All had undergone surgery to remove a tumor and were receiving chemotherapy. The women, aged 60 and under, all had cancer that had spread to their lymph nodes, indicating the disease was likely to spread.

The women received one of three treatments -- AC/T, EC/T, or CEF -- and results revealed that for every 100 women who received EC/T or CEF, 10 women would suffer a recurrence. For every 100 women who received AC/T, 15 women would relapse.

The lead researcher of the study says it's too soon to say whether EC/T and CEF are more effective in the long-term. So participants will be followed for some time while researchers will try to make sense of their initial findings. In the meantime, they suspect AC/T will continue to be widely used because of its lesser side effects.